ABL1 and lung carcinoma: Here, we demonstrate for the first time in the context of a KrasLSL-G12D; p53fl/fl (KP) mouse model of lung cancer that ABL kinase inhibition sensitizes primary lung adenocarcinomas to treatment with the chemotherapeutic agent, docetaxel.